Coldstream Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $16.1M | Buy |
133,666
+11,824
| +10% | +$1.37M | 0.2% | 67 |
|
|
2025
Q4 | $12.8M | Sell |
121,842
-1,524
| -1% | -$143K | 0.17% | 78 |
|
|
2025
Q3 | $10.4M | Buy |
123,366
+13,940
| +13% | +$1.15M | 0.14% | 88 |
|
|
2025
Q2 | $8.67M | Buy |
109,426
+6,076
| +6% | +$483K | 0.14% | 93 |
|
|
2025
Q1 | $9.28M | Sell |
103,350
-7,655
| -7% | -$715K | 0.2% | 72 |
|
|
2024
Q4 | $11M | Buy |
111,005
+8,606
| +8% | +$887K | 0.24% | 58 |
|
|
2024
Q3 | $11.6M | Buy |
102,399
+7,544
| +8% | +$896K | 0.25% | 60 |
|
|
2024
Q2 | $11.7M | Buy |
94,855
+457
| +0.5% | +$58.9K | 0.29% | 48 |
|
|
2024
Q1 | $12.5M | Buy |
94,398
+3,197
| +4% | +$394K | 0.32% | 47 |
|
|
2023
Q4 | $9.94M | Buy |
91,201
+3,813
| +4% | +$396K | 0.28% | 50 |
|
|
2023
Q3 | $9M | Buy |
87,388
+8,089
| +10% | +$872K | 0.29% | 51 |
|
|
2023
Q2 | $9.15M | Sell |
79,299
-2,368
| -3% | -$269K | 0.29% | 50 |
|
|
2023
Q1 | $8.69M | Buy |
81,667
+115
| +0.1% | +$12.4K | 0.29% | 51 |
|
|
2022
Q4 | $9.05M | Buy |
+81,552
| New | +$8.34M | 0.33% | 45 |
|
|
2022
Q2 | $7.98M | Buy |
87,551
+5,954
| +7% | +$528K | 0.31% | 56 |
|
|
2022
Q1 | $6.7M | Buy |
81,597
+1,938
| +2% | +$153K | 0.23% | 65 |
|
|
2021
Q4 | $6.11M | Buy |
79,659
+27,358
| +52% | +$2.18M | 0.19% | 80 |
|
|
2021
Q3 | $4.34M | Sell |
52,301
-8,257
| -14% | -$628K | 0.21% | 65 |
|
|
2021
Q2 | $4.71M | Sell |
60,558
-3,606
| -6% | -$268K | 0.19% | 77 |
|
|
2021
Q1 | $4.72M | Buy |
64,164
+2,410
| +4% | +$178K | 0.28% | 55 |
|
|
2020
Q4 | $4.82M | Buy |
61,754
+12,001
| +24% | +$918K | 0.29% | 45 |
|
|
2020
Q3 | $3.94M | Buy |
49,753
+362
| +0.7% | +$28.4K | 0.33% | 45 |
|
|
2020
Q2 | $3.65M | Sell |
49,391
-1,151
| -2% | -$86.6K | 0.33% | 47 |
|
|
2020
Q1 | $3.71M | Buy |
50,542
+756
| +2% | +$59.4K | 0.41% | 35 |
|
|
2019
Q4 | $4.32M | Sell |
49,786
-211
| -0.4% | -$17.3K | 0.35% | 48 |
|
|
2019
Q3 | $4.02M | Sell |
49,997
-1,187
| -2% | -$95.1K | 0.34% | 54 |
|
|
2019
Q2 | $4.09M | Buy |
51,184
+586
| +1% | +$44.9K | 0.34% | 55 |
|
|
2019
Q1 | $4.01M | Buy |
50,598
+34,547
| +215% | +$2.58M | 0.35% | 54 |
|
|
2018
Q4 | $1.17M | Buy |
16,051
+2,601
| +19% | +$184K | 0.11% | 113 |
|
|
2018
Q3 | $911K | Buy |
13,450
+1,476
| +12% | +$94K | 0.08% | 162 |
|
|
2018
Q2 | $693K | Buy |
11,974
+314
| +3% | +$17.7K | 0.07% | 165 |
|
|
2018
Q1 | $606K | Buy |
11,660
+1,593
| +16% | +$86K | 0.07% | 172 |
|
|
2017
Q4 | $540K | Sell |
10,067
-35,953
| -78% | -$1.99M | 0.06% | 188 |
|
|
2017
Q3 | $2.81M | Buy |
46,020
+35
| +0.1% | +$2.12K | 0.33% | 65 |
|
|
2017
Q2 | $2.81M | Buy |
45,985
+3,091
| +7% | +$188K | 0.36% | 52 |
|
|
2017
Q1 | $2.6M | Buy |
42,894
+3,025
| +8% | +$184K | 0.36% | 48 |
|
|
2016
Q4 | $2.24M | Buy |
39,869
+32,336
| +429% | +$1.89M | 0.36% | 52 |
|
|
2016
Q3 | $449K | Sell |
7,533
-517
| -6% | -$30.2K | 0.08% | 129 |
|
|
2016
Q2 | $443K | Sell |
8,050
-249
| -3% | -$13.3K | 0.08% | 169 |
|
|
2016
Q1 | $419K | Buy |
8,299
+1,975
| +31% | +$96.7K | 0.08% | 133 |
|
|
2015
Q4 | $319K | Buy |
6,324
+665
| +12% | +$33.5K | 0.07% | 126 |
|
|
2015
Q3 | $267K | Sell |
5,659
-157
| -3% | -$8.34K | 0.07% | 130 |
|
|
2015
Q2 | $316K | Buy |
+5,816
| New | +$326K | 0.08% | 118 |
|
|
2014
Q4 | – | Sell |
-4,057
| Closed | -$229K | – | 212 |
|
|
2014
Q3 | $229K | Buy |
4,057
+82
| +2% | +$4.61K | 0.07% | 146 |
|
|
2014
Q2 | $219K | Sell |
3,975
-429
| -10% | -$23.4K | 0.06% | 159 |
|
|
2014
Q1 | $239K | Sell |
4,404
-1,282
| -23% | -$66.4K | 0.08% | 140 |
|
|
2013
Q4 | $272K | Sell |
5,686
-28,555
| -83% | -$1.31M | 0.09% | 127 |
|
|
2013
Q3 | $1.56M | Buy |
34,241
+414
| +1% | +$18.9K | 0.51% | 56 |
|
|
2013
Q2 | $1.5M | Buy |
+33,827
| New | +$1.51M | 0.51% | 58 |
|
Other funds holding MRK
VCM
VPM
Coldstream Capital Management's MRK Position: Q1 2026 in Review
Coldstream Capital Management increased its Merck (MRK) stake by 9.7% in Q1 2026, buying an estimated $1.37M and bringing the position to 133,666 shares worth $16.1M. The position accounts for 0.2% of the portfolio, ranked #67.
Coldstream Capital Management first reported a position in MRK in Q2 2013 and has held it in 49 quarters since. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Coldstream Capital Management held 133,666 shares of Merck worth $16.1M as of Q1 2026.
- Coldstream Capital Management bought 11,824 Merck shares in Q1 2026, an estimated $1.37M.
- Merck made up 0.2% of Coldstream Capital Management's portfolio in Q1 2026, its #67 holding.
- Coldstream Capital Management first reported a position in Merck in Q2 2013 and has held it in 49 quarters since.
- 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Coldstream Capital Management's 13F filing for Q1 2026, filed 8 May 2026.